HYPERTENSION Rahmayanti jus’an Rika hartina Rasna Rudi lestari Roselina Syafitrah oktavianti muklis Grup 6 Rusmiati Sepriadi nisa lamba Siti hajar iskandar.

Presentasi berjudul: "HYPERTENSION Rahmayanti jus’an Rika hartina Rasna Rudi lestari Roselina Syafitrah oktavianti muklis Grup 6 Rusmiati Sepriadi nisa lamba Siti hajar iskandar."— Transcript presentasi:

1 HYPERTENSION Rahmayanti jus’an Rika hartina Rasna Rudi lestari Roselina Syafitrah oktavianti muklis Grup 6 Rusmiati Sepriadi nisa lamba Siti hajar iskandar Sinta Sri lestari

2 BACKGROUND Epidemiological studies report that 1 in 3 U.S. adults have hypertension, with 65 milion people in the United States having BPs 140/90 mmHg or higher or taking antihypertensive medications. Age, gender, and etnic difference are evident. African Americans in the United States develop hypertension earlier, have more significantly elevated BP, and have more incidence of hypertension than white women.

3 DEFENITION Hypertension or high blood pressure (BP) is an important medical and public health problem. Hypertension is defined as a persistent SPP ≥ 140 mmHg, DBP ≥ 90 mmHg, or current use of antihypertensive medication

4 Classification of Blood Pressure for Adults 18 Years of Age and Older Systolic (mmHg) diastolic (mmHg) Normal > 120 and <80 Prehypertension 120 – 139 or 80 - 90 Hypertension Stage 1 140 – 159 or 90 -99 Stage 2 ≥ 160 or ≥ 100

5 Primary Hypertensio n. Primary (essential or idiopathic) hypertension is elevated BP without an identified cause Secondary Hypertension. Secondary hypertension is elevated BP with a specific cause can be identified and corrected Etiologi

6 These secondary symptoms include fatigue, reduced activity tolerance, dizziness, palpitations, angina, and dypsnea. In the past, symptoms if hypertension were thought to include headache, nosebleeds, and dizziness However, patients with hypertensive crisis (discussed later in the chapter) may experience severe headaches, dyspnea, anxiety, and nosebleeds. CLINICAL MANIFESTASIONS

7 Nursing diagnose Dificiente knowledge common related factor with lack of exposure Risk for ineffective therapheutic regimen management common risk factor with complexity of therapeutic regijment.

8 THANKS YOU